Statins and their role in acute pancreatitis: Case report and literature review

doi:10.4292/wjgpt.v5.i3.191

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3423)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

300

WORD

231

HTML

1747

Figures (1-1)

132

Tables (1-1)

266

Sum=2676

Aug 6, 2014 (publication date) through Apr 30, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastrointest Pharmacol Ther. Aug 6, 2014; 5(3): 191-195
Published online Aug 6, 2014. doi: 10.4292/wjgpt.v5.i3.191

Statins and their role in acute pancreatitis: Case report and literature review

Denzil Etienne, Yousef Reda

Denzil Etienne, Yousef Reda, Department of Medicine, SUNY Upstate Medical University, Syracuse, NY 13210, United States

Author contributions: Both the authors solely contributed to this paper.

Correspondence to: Denzil Etienne, MD, Department of Medicine, SUNY Upstate Medical University, 750 East Harrison Street, Syracuse, NY 13210, United States. denziletienne@gmail.com

Telephone: +1-315-4644480 Fax: +1-315-4644484

Received: May 14, 2014
Revised: June 20, 2014
Accepted: June 27, 2014
Published online: August 6, 2014

Core Tip

Core tip: Statins may reduce the risk of developing an acute episode of pancreatitis through anti-inflammatory perturbation of the systemic inflammatory response pathway. However, it appears that these drugs may also carry a concomitant long-term risk of pancreatitis through a buildup of toxic metabolite/s.